Login to Your Account



Pharma: Other News To Note


Thursday, October 31, 2013
• Impax Laboratories Inc., of Hayward, Calif., and Tolmar Therapeutics Inc., of Ft. Collins, Colo., said the FDA granted final approval of Tolmar’s abbreviated new drug application for its generic version of Solaraze Gel (diclofenac sodium 3 percent).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription